Latest:
Dr. Eskelund on Outcomes of TP53-Mutated MCL
Christian Winther Eskelund, MD, Copenhagen University Hospital, Rigshospitalet, discusses outcomes for patients with TP53-mutated mantle cell lymphoma (MCL).
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Christie J. Hilton, DO
Latest:
Dr Hilton on Trastuzumab Deruxtecan in HER2+ Metastatic Breast Cancer
Christie J. Hilton, DO, discusses the first-line standard of care and changes in the second-line SOC, including key findings from the phase 3 DESTINY-Breast03 trial, in patients with HER2-positive metastatic breast cancer.
Christin Melton & Christina Loguidice
Latest:
Introducing the Oncology Specialty Group
Oncology & Biotech News is now united with the experienced publishing, editorial, and creative staff of Oncology Net Guide and OncLive Nursing under the Oncology Specialty Group umbrella, which also includes our newest publication, Contemporary Oncology.
Christin Melton, ELS
Latest:
Bounty of New HCC Therapies Spurs Need for More Research
The optimal integration of new drugs into the treatment paradigm of HCC requires several key developments, including greater research into biomarkers that would help inform therapy choices, earlier treatment for patients diagnosed with HCC, and clinical trials that test combination strategies.
Christina M. Annunziata, MD, PhD
Latest:
Dr. Annunziata on Efforts to Prevent Gynecologic Cancers
Christina M. Annunziata, MD, PhD, investigator, Women's Malignancies Branch, head, Translational Genomics Section, National Cancer Institute, discusses the importance on efforts being done to prevent gynecologic cancers.
Christine Bestvina, MD
Latest:
Leveraging ctDNA Platforms in High-Risk Patients: Current Applications and Future Potential
Panelists discuss how they currently utilize emerging ctDNA platforms for high-risk patients and explore whether these advancements will soon become standard practice in clinical decision-making.
Christine M. Duffy, MD, MPH
Latest:
Survivorship Starts at Diagnosis in Breast Cancer
The inclusion of patients from the time of diagnosis and encompassing family, friends, and caregivers is central to moving survivorship care forward, especially for breast cancer survivorship, which has high survival rates for early disease and the emergence of novel treatments for advanced cancers.
Christophe Mariette, MD, PhD
Latest:
Dr. Mariette on Takeaways from a Study of Esophageal and Gastric Cancer Surgery
Christophe Mariette, MD, PhD, surgical oncologist, professor of Surgery, University Hospital of Lille, discusses the main takeaways from a study investigating postoperative mortality after patients undergo surgery for esophageal and gastric cancer.
Christopher Crane, MD
Latest:
Dr. Crane on the Use of Proton Therapy and the MR-Linear Accelerator in GI Malignancies
Christopher Crane, MD, vice chair, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, discusses the emergence and success of new technologies in the treatment of patients with gastrointestinal (GI) malignancies.
Christopher Dittus, DO, MPH
Latest:
How to Survive With Limited Finances (and a Family) as a Hematology-Oncology Fellow
If you are anything like me, despite working incredibly hard, not getting paid adequately for many years, and accumulating an incredible amount of debt, you could not imagine any other career.